๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Lymphoproliferative Disorders

A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype NCT07341867Phase 11 site๐Ÿ“ Boston Andrew Hantel, MD ยท Tests: Dexamethasone, Bortezomib, LENALIDOMIDE, Daratumumab, Carboplatin A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 NCT07623798Phase 31 site๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: Pomalidomide Capsules, Bortezomib for Injection, Daratumumab Injection (Subcutaneous Injection), IBI3003, Selinexor Tabโ€ฆ Sample Collection and Tracking for the Developmental Therapeutics Clinic NCT03269578n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) NCT05519085Phase 3266 sites๐Ÿ“ Los Alamitos๐Ÿ“ San Diego๐Ÿ“ West Hollywood Celgene ยท Tests: mezigdomide, Pomalidomide, Bortezomib, Dexamethasone Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia NCT05281809Phase 21 site๐Ÿ“ Pittsburgh John Lister ยท Tests: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous) Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE) NCT06534463n/a1 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: All treatment regimen selections and usage will be determined by the physician based on clinical practice and/or the reโ€ฆ Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma NCT05530421Phase 23 sites๐Ÿ“ Coral Gables๐Ÿ“ Deerfield Beach๐Ÿ“ Miami University of Miami ยท Tests: Selinexor, Venetoclax, Dexamethasone Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study NCT05846763n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia NCT05827549Phase 210 sites๐Ÿ“ Daegu๐Ÿ“ Daejeon๐Ÿ“ Hwasun Ho Joon Im ยท Tests: Reinduction(4weeks), Cosolodation 1st(3weeks), Consolidation 2nd(3weeks), Blinatumomab 1st(High Risk Group)_4 Weeks, Blโ€ฆ Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention NCT06686108Phase 21 site๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ ยท Tests: Azacitidine (AZA) Days 1 - 5, Decitabine (DAC), Venetoclax Sleep Apnea in Patients With MGUS and MM NCT04114084n/a1 site๐Ÿ“ Iowa City Michael Tomasson ยท Tests: Bone Marrow Aspirate and Biopsy Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) NCT07445984NA1 site๐Ÿ“ Parma Azienda Ospedaliero-Universitaria di Parma ยท Tests: Genetic, molecular and/or omics analyses CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies NCT07106749Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: CD180 CART Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies NCT07284433Phase 1, Phase 213 sites๐Ÿ“ Chicago๐Ÿ“ Evanston๐Ÿ“ Providence AvenCell Therapeutics, Inc. ยท Tests: Cyclophosphamide (Non-IMP, Lymphodepletion), Fludarabine (Non-IMP, Lymphodepletion), Allo-QuadCAR01-T DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12) NCT07059650Phase 1, Phase 213 sites๐Ÿ“ Beijing๐Ÿ“ Changsha๐Ÿ“ Chengdu Dizal Pharmaceuticals ยท Tests: DZD8586+R-CHOP, DZD8586+R-GemOx, DZD8586+BR Nurture by Nature Feasibility Study NCT07780123NA1 site๐Ÿ“ Frederiksberg Ina Olmer Specht ยท Tests: Nature-base intervention Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662Phase 1, Phase 21 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography, Cytarabine This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma NCT07121946Phase 16 sites๐Ÿ“ Duarte๐Ÿ“ St Louis๐Ÿ“ Buffalo LTZ Therapeutics, Inc. ยท Tests: LTZ-301, LTZ-301, LTZ-301 CAV Regimen for R/R Ph- B-ALL NCT05657652NA1 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: cladribine, cytarabine,venetoclax Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular Lymphoma NCT07299149Phase 22 sites๐Ÿ“ Tianjin๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Induction Therapy: Zanubrutinib, obinutuzumab, lenalidomide, Maintenance therapy: Zanubrutinib, lenalidomide The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome NCT07275190NA1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia ยท Tests: Blood draw for the laboratory assessment Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma NCT06182774Phase 331 sites๐Ÿ“ Edmonton๐Ÿ“ Kelowna๐Ÿ“ Vancouver Canadian Cancer Trials Group ยท Tests: Daratumumab, Lenalidomide, Dexamethasone, Isatuximab A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies NCT05908409Phase 1, Phase 211 sites๐Ÿ“ Santander๐Ÿ“ Salamanca๐Ÿ“ Barcelona IDP Discovery Pharma S.L. ยท Tests: IDP-121 5HTP Regulation Of Asthma In Children NCT04160910Phase 21 site๐Ÿ“ Indianapolis Indiana University ยท Tests: 5-Hydroxytryptophan, Placebo Pediatric Orthopaedic Implant Safety & Efficacy NCT05361980n/a1 site๐Ÿ“ Vancouver University of British Columbia ยท Tests: Pediatric orthopaedic implant Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas NCT06176690Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Houston Baylor College of Medicine ยท Tests: C7R.CD30.CAR-EBVST cells Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma NCT07763210Phase 21 site๐Ÿ“ Nashville Vanderbilt-Ingram Cancer Center ยท Tests: Therapeutic Hydrocortisone, Cytarabine, Dexamethasone, Methylprednisolone, Cyclophosphamide Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Daratumumab SC Ovarian Hyperstimulation Syndrome Prevention NCT06739759NA2 sites๐Ÿ“ Giza๐Ÿ“ Giza Aljazeera Hospital ยท Tests: Antagonist protocol for IVF, Modified Agonist protocol for IVF with additive treatments as HCQ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy